Dean L. Winslow

2.4k citations

41 papers · 1.5k indexed · h-index 21

Co-authors: Sena Garber Carol Reid André C. Kalil David N. Gilbert Henry Masur Michael Klompas Wesley W. Emmons Helmut Jacobsen
Topics: HIV/AIDS drug development and treatment (21 papers)HIV Research and Treatment (18 papers)HIV/AIDS Research and Interventions (11 papers)
Cited by: Virology Infectious Diseases Applied Microbiology and Biotechnology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Annals of Internal Medicine
Partner nations: United States Slovakia United Kingdom

In The Last Decade

Dean L. Winslow

38 papers receiving 1.5k citations

Peers

Countries citing papers authored by Dean L. Winslow

Since Specialization

Citations

This map shows the geographic impact of Dean L. Winslow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean L. Winslow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean L. Winslow more than expected).

Fields of papers citing papers by Dean L. Winslow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean L. Winslow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean L. Winslow. The network helps show where Dean L. Winslow may publish in the future.

Co-authorship network of co-authors of Dean L. Winslow

This figure shows the co-authorship network connecting the top 25 collaborators of Dean L. Winslow. A scholar is included among the top collaborators of Dean L. Winslow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean L. Winslow. Dean L. Winslow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	‘Suffer the little children …’ Lessons from the EPPICC study, concern about the future, and a call to action 2025 ·AIDS ·Dean L. Winslow	0
2	The hospital medicine‐infectious diseases career path: Opportunities and insights 2024 ·Journal of Hospital Medicine ·Marie E. Wang,Dean L. Winslow,Samir S. Shah	0
3	Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper 2023 ·Clinical Infectious Diseases ·Chanu Rhee,Jeffrey R. Strich,Kathleen Chiotos,David C. Classen,Sara E. Cosgrove,(unknown),Emily L. Heil,Sameer S. Kadri,André C. Kalil,David N. Gilbert,Henry Masur,Edward Septimus,Daniel A. Sweeney,(unknown),Dean L. Winslow,Donald M. Yealy,Michael Klompas	20
4	Suppurative lymphadenitis caused by hypermucoid-variant Klebsiella in a Polynesian woman: a case report 2020 ·Diagnostic Microbiology and Infectious Disease ·Bo Sun,(unknown),Dean L. Winslow	2
5	Efavirenz Plasma Concentrations and Cytochrome 2B6 Polymorphisms 2010 ·Annals of Pharmacotherapy ·(unknown),John O’Brien,Jessica Song,Rajul A. Patel,Dean L. Winslow	16
6	Discovery of potent and selective inhibitors of procollagen C‐proteinase for the treatment of fibrotic disorders 2004 ·International Journal of Experimental Pathology ·Richard P. Butt,J.P. Huggins,Doris Greiling,(unknown),(unknown),Dean L. Winslow,(unknown),Simon E. Lewis,Shannon L. Ward,(unknown),John Owen,(unknown),M G Collis,Simon Bailey,(unknown),Gavin A. Whitlock,(unknown),Kim James,Andrew B. McElroy,Julian Blagg	1
7	HIV-1 Protease and Reverse Transcriptase Mutation Patterns Responsible for Discordances Between Genotypic Drug Resistance Interpretation Algorithms 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown),Bradley J. Betts,Françoise Brun‐Vézinet,Anne–Mieke Vandamme,Diane Descamps,Kristel Van Laethem,K.M. Smith,Jonathan Schapiro,Dean L. Winslow,Caroline Reid,Robert W. Shafer	74
8	Clinical Resistance Patterns and Responses to Two Sequential Protease Inhibitor Regimens in Saquinavir and Reverse Transcriptase Inhibitor–Experienced Persons 1999 ·The Journal of Infectious Diseases ·Jody Lawrence,Jonathan Schapiro,Mark A. Winters,José G. Montoya,Andrew Zolopa,Rick L. Pesano,B. Efron,Dean L. Winslow,T. C. Merigan	51
9	Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266 1996 ·AIDS ·Dean L. Winslow,Sena Garber,Carol Reid,Helen Scarnati,David Baker,Marlene M. Rayner,Elizabeth D. Anton	44
10	Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic Millimeter 1996 ·New England Journal of Medicine ·Louis D. Saravolatz,Dean L. Winslow,Gary Collins,James S. Hodges,Carla Pettinelli,Daniel S. Stein,Norman Markowitz,Randall Reves,Mark O. Loveless,Lawrence R. Crane,Melanie Thompson,Donald I. Abrams	120
11	Limited Sequence Diversity of the HIV Type 1 Protease Gene from Clinical Isolates and in Vitro Susceptibility to HIV Protease Inhibitors 1995 ·AIDS Research and Human Retroviruses ·Dean L. Winslow,(unknown),Robert J. King,Helen Scarnati,(unknown),(unknown)	46
12	Identification of a clinical isolate of HIV-1 with an isoleucine at position 82 of the protease which retains susceptibility to protease inhibitors 1995 ·Antiviral Research ·Robert W. King,Dean L. Winslow,Sena Garber,Helen Scarnati,(unknown),(unknown),Michaël Otto	25
13	Characterization of human immunodeficiency virus type 1 mutantswith decreased sensitivity to proteinase inhibitor Ro 31-8959 1995 ·Virology ·Helmut Jacobsen,(unknown),Dean L. Winslow,Jane Craig,(unknown),I. B. R. Duncan,Jan Mous	173
14	Multiple Mutations in the Human Immunodeficiency Virus Protease Gene Are Responsible for Decreased Susceptibility to Protease Inhibitors 1995 ·Antiviral chemistry & chemotherapy ·Robert W. King,Sena Garber,Dean L. Winslow,Carol Reid,Lee T. Bacheler,Elizabeth D. Anton,Michaël Otto	27
15	In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitor 1994 ·AIDS ·Dean L. Winslow,Douglas L. Mayers,Helen Scarnati,James R. Lane,(unknown),Michaël Otto	5
16	Construction of Infectious Molecular Clones of HIV-1 Containing Defined Mutations in the Protease Gene 1994 ·Biochemical and Biophysical Research Communications ·Dean L. Winslow,Elizabeth D. Anton,Robert A. Horlick,Robert J. Zagursky,R.J. Tritch,Helen Scarnati,Kate G. Ackerman,Lee T. Bacheler	11
17	In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. 1993 ·Proceedings of the National Academy of Sciences ·(unknown),Sena Garber,Dean L. Winslow,Carol Reid,Paul E. Aldrich,(unknown),Catherine E. Patterson,C. Nicholas Hodge,Y S Cheng	114
18	Rhodococcus equi Infection in the Patient with AIDS: Literature Review and Report of an Unusual Case 1990 ·Clinical Infectious Diseases ·Wesley W. Emmons,(unknown),Dean L. Winslow	82
19	Brief report: Ciprofloxacin versus ceftazidime in serious infections 1989 ·The American Journal of Medicine ·John F. Reinhardt,(unknown),Dean L. Winslow,William J. Holloway	1
20	Cefmetazole treatment of intra-abdominal infection 1989 ·Journal of Antimicrobial Chemotherapy ·William J. Holloway,Dean L. Winslow,J. F. Reinhardt	15

About Dean L. Winslow

Dean L. Winslow is a scholar working on Virology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (18 papers) and HIV/AIDS Research and Interventions (11 papers). The work is most often cited by research in Virology (889 citations), Infectious Diseases (1.0k citations) and Applied Microbiology and Biotechnology (70 citations). Dean L. Winslow has collaborated with scholars based in United States, Slovakia and United Kingdom. Frequent co-authors include Sena Garber, Carol Reid, André C. Kalil, David N. Gilbert, Henry Masur, Michael Klompas, Wesley W. Emmons, Helmut Jacobsen, Jan Mous and Jane Craig. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact